Pharmaceuticals News and Research

RSS
Ban called for on newer birth control pills

Ban called for on newer birth control pills

Britain to debate availability of HRT and the pill over the counter

Britain to debate availability of HRT and the pill over the counter

Many low-income Medicare beneficiaries receive no help from PAPs

Many low-income Medicare beneficiaries receive no help from PAPs

GlaxoSmithKline issues update on US patent litigation regarding Valtrex

GlaxoSmithKline issues update on US patent litigation regarding Valtrex

Rapid transport of large polymeric nanoparticles in fresh undiluted human mucus

Rapid transport of large polymeric nanoparticles in fresh undiluted human mucus

Antipodean Pharma commences phase 2 trial in hepatitis C

Antipodean Pharma commences phase 2 trial in hepatitis C

Direct synthesis of polymer nanocapsules with a noncovalently tailorable surface

Direct synthesis of polymer nanocapsules with a noncovalently tailorable surface

Disappointing end to trials of new gel to protect women against AIDS

Disappointing end to trials of new gel to protect women against AIDS

FDA approves Neuren's phase 3 Glypromate trial

FDA approves Neuren's phase 3 Glypromate trial

Novartis' day in court could leave millions without AIDS drugs

Novartis' day in court could leave millions without AIDS drugs

Access Pharmaceuticals issued U.S. patent

Access Pharmaceuticals issued U.S. patent

TV ads for drugs high on the emotions but low on facts

TV ads for drugs high on the emotions but low on facts

Thailand the latest drug patent buster

Thailand the latest drug patent buster

Guyanese Health Ministry to provide $450,000 for HIV/AIDS programs

Guyanese Health Ministry to provide $450,000 for HIV/AIDS programs

Panel recommends FDA to not create specific effectiveness standard for oral contraceptive approvals

Panel recommends FDA to not create specific effectiveness standard for oral contraceptive approvals

Thailand plans to break antiretroviral patents

Thailand plans to break antiretroviral patents

A plasminogen-activating protease specifically controls the development of primary pneumonic plague

A plasminogen-activating protease specifically controls the development of primary pneumonic plague

More med schools, hospitals ban gifts from pharmaceutical companies

More med schools, hospitals ban gifts from pharmaceutical companies

Access Pharmaceuticals receives MuGard patent allowance

Access Pharmaceuticals receives MuGard patent allowance

Lessons from Vioxx litigation

Lessons from Vioxx litigation

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.